1. Bariety J, Bellon B, Sapin C, Kuhn J, Druet P, Hinglais N, Giraud JP, Belair MF, Paing M, Laliberte F (1981) Immunoenzymatic study of the protein pathway through the glomerular barrier in rat glomerulonephritides. Kidney Int 19: 663–677
2. Bernard J, Paul R, Boiron M, Jacquillat CI, Maral R (eds) (1969) Rubidomycin: a new agent against cancer. Springer-Verlag, New York Berlin Heidelberg, pp 100–101
3. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB (1982) Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 46: 16–23
4. Buja LM, Ferrans VJ, Mayer RJ, Roberts WC, Henderson ES (1973) Cardiac ultrastructural changes induced by daunorubicin therapy. Cancer 32: 771–788
5. Cameron JS, Turner DR, Ogg CS, Sharpstone P, Brown CB (1974) The nephrotic syndrome in adults with ‘minimal change’ glomerular lesions. QJ Med 43: 461–488